Awal Shikha, Bhalotra Anju Romina, Sharma Saurabh
Department of Anaesthesiology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
Department of Anaesthesiology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.
J Anaesthesiol Clin Pharmacol. 2022 Apr-Jun;38(2):300-308. doi: 10.4103/joacp.JOACP_394_20. Epub 2022 May 7.
Early recovery is desirable after day care surgery. Intravenous lidocaine has anti-inflammatory, anti-hyperalgesic, and analgesic effects and by reducing postoperative pain, nausea, vomiting, and duration of postoperative ileus and hospital stay, might be a useful adjuvant to improve recovery after gynecological laparoscopic surgery.
Fifty female patients, aged 18-55 years, undergoing gynecological laparoscopic surgery were randomly allocated to two groups. In Group L, patients received intravenous lidocaine 1.5 mg/kg at induction of anesthesia followed by infusion of 2 mg/kg/hour until the completion of surgery and in Group NS, patients received normal saline infusion. The Global QoR-40 score at 24 hours, pain score in PACU and at 24 hours, nausea/vomiting, PADSS score in PACU and analgesic consumption over 24 hours were assessed and data were analyzed using SPSS version 17 software.
Demographic data were comparable in both groups. The mean Global QoR-40 score in Group L was 197.30 ± 2.3 versus 178.74 ± 6.02 in Group NS (P < 0.001). The mean time to attain PADSS ≥9 was 50 min shorter in Group L than in Group NS (P < 0.001). Nausea, vomiting, and anti-emetic requirement were also significantly reduced in Group L as compared to Group NS (P = 0.005) as was the mean pain score over 24 h (P < 0.001) and the total analgesic consumption over the first 24 h after surgery (P < 0.005).
Intraoperative intravenous lidocaine infusion resulted in an improved overall Quality of Recovery in patients undergoing ambulatory gynecological surgery.
日间手术术后早期恢复是理想的。静脉注射利多卡因具有抗炎、抗痛觉过敏和镇痛作用,通过减轻术后疼痛、恶心、呕吐以及缩短术后肠梗阻持续时间和住院时间,可能是改善妇科腹腔镜手术后恢复的一种有用辅助药物。
50例年龄在18 - 55岁接受妇科腹腔镜手术的女性患者被随机分为两组。L组患者在麻醉诱导时静脉注射1.5 mg/kg利多卡因,随后以2 mg/(kg·小时)的速度输注直至手术结束;NS组患者接受生理盐水输注。评估术后24小时的全球恢复质量-40(Global QoR-40)评分、麻醉后恢复室(PACU)及术后24小时的疼痛评分、恶心/呕吐情况、PACU中的患者术后恢复情况评分系统(PADSS)评分以及24小时内的镇痛药物消耗量,并使用SPSS 17版软件进行数据分析。
两组的人口统计学数据具有可比性。L组的平均Global QoR-40评分为197.30 ± 2.3,而NS组为178.74 ± 6.02(P < 0.001)。L组达到PADSS≥9的平均时间比NS组短50分钟(P < 0.001)。与NS组相比,L组的恶心、呕吐及止吐药物需求也显著减少(P = 0.005),24小时的平均疼痛评分(P < 0.001)以及术后首24小时的总镇痛药物消耗量(P < 0.005)亦是如此。
术中静脉输注利多卡因可改善门诊妇科手术患者的总体恢复质量。